tangeretin has been researched along with Adenocarcinoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coyne, CP; Narayanan, L | 1 |
| Chen, WJ; Ho, CT; Lin, JK; Lin-Shiau, SY; Pan, MH | 1 |
| Canada, AT; Nguyen, TD | 1 |
| Bracke, ME; Mareel, MM; Van Roy, FM | 1 |
| Boterberg, T; Bracke, ME; Depypere, HT; Mareel, MM; Nuytinck, M; Serreyn, R; Van Marck, VL; Vanluchene, E; Vennekens, KM | 1 |
1 review(s) available for tangeretin and Adenocarcinoma
| Article | Year |
|---|---|
The E-cadherin/catenin complex in invasion and metastasis.
Topics: Adenocarcinoma; alpha Catenin; Animals; beta Catenin; Breast Neoplasms; Cadherins; Cell Polarity; Cytoskeletal Proteins; Cytoskeleton; Desmoplakins; Dogs; Epithelium; Fetal Proteins; Flavones; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Macromolecular Substances; Multigene Family; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Protein Conformation; Receptor, IGF Type 1; Structure-Activity Relationship; Tamoxifen; Trans-Activators; Tretinoin; Tumor Cells, Cultured | 1996 |
4 other study(ies) available for tangeretin and Adenocarcinoma
| Article | Year |
|---|---|
Carnosic Acid, Tangeretin, and Ginkgolide-B Anti-neoplastic Cytotoxicity in Dual Combination with Dexamethasone-[anti-EGFR] in Pulmonary Adenocarcinoma (A549).
Topics: A549 Cells; Abietanes; Adenocarcinoma; Antineoplastic Agents; Cell Proliferation; Dexamethasone; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; ErbB Receptors; Flavones; Ginkgolides; Humans; Lactones; Lung Neoplasms; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |
Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cell Division; Colonic Neoplasms; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; DNA-Binding Proteins; Flavones; Flavonoids; G1 Phase; Humans; Kinetics; Phosphorylation; Phytotherapy; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Retinoblastoma Protein; Structure-Activity Relationship; Time Factors; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2002 |
Citrus flavonoids stimulate secretion by human colonic T84 cells.
Topics: Adenocarcinoma; Carbachol; Chlorides; Citrus; Colon; Colonic Neoplasms; Cyclic AMP; Cyclic GMP; Drug Synergism; Flavanones; Flavones; Flavonoids; Glycosylation; Humans; Kinetics; Tumor Cells, Cultured | 1993 |
Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Drug Synergism; Female; Flavones; Flavonoids; Gene Expression Regulation, Neoplastic; Killer Cells, Natural; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Plant Extracts; Tamoxifen; Tumor Cells, Cultured | 1999 |